LeonardWJ, NoguchiM, RussellSM, McBrideOW. The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor γ chain as a common γ chain, γc. Immunolog Rev1994;138:61–86.
2.
ConleyME. Molecular approaches to analysis of X-linked immunodeficiencies. Annu Rev Immunol1992;10:215–38.
3.
LeonardWJ. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu Rev Med1996;47:229–39.
4.
NoguchiM, YiH, RosenblattHM, FilipovichAH, AdelsteinS, ModiWS, McBrideOW, LeonardWJ. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell1993;73:147–57.
5.
TakeshitaT, AsaoH, OhtaniK, IshiiN, KumakiS, TanakaN, MunakataH, NakamuraM, SugamuraK. Cloning of the γ chain of the human IL-2 receptor. Science1992;257:379–82.
6.
BazanJF. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA1990;87:6934–8.
7.
SiegelJP, SharonM, SmithPL, LeonardWJ. The IL-2 receptor β chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science1987;238:75–8.
8.
NakamuraY, RussellSM, MessSA, FriedmannM, ErdosM, FrancoisC, JacquesY, AdelsteinS, LeonardWJ. Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signaling. Nature1994;369:330–3.
9.
NelsonBH, LordAD, GreenbergPD. Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell prolif-eration. Nature1994;369:333–6.
10.
NoguchiM, AdelsteinS, CaoX, LeonardWJ. Characterization of the human interleukin-2 receptor γ chain gene. J Biol Chem1993;268:13601–8.
11.
de Saint BasileGD, ArveilerB, OberleI, MalcolmS, LevinskyRJ, LauYL, HofkerM, DebreM, FischerA, FriscelliC, MandelJL. Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-Xq13. Proc Natl Acad Sci USA1987;84:7576–9.
WeinbergK, ParkmanR. Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. N Engl J Med1990;322:1718–23.
14.
SchorleH, HoltschkeT, HunigT, SchimplA, HorakI. Development and function of T cells in mice rendered interleukin-2 defi-cient by gene targeting. Nature1991;352:621–4.
15.
PuckJM, DeschenesSM, PorterJC, DutraAS, BrownCJ, WillardHF, HenthornPS. The interleukin-2 receptor γ chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Human Molec Genet1993;2:1099–104.
16.
DiSantoJP, Dautry-VarsatA, CertainS, FischerA, de Saint BasileG. Interleukin-2 (IL-2) receptor γ chain mutations in X-linked severe combined immunodeficiency disease result in the loss of high-affinity IL-2 receptor binding. Eur J Immunol1994;24:475–9.
17.
DiSantoJP, Rieux-LaucatF, Dautry-VarsatA, FischerA, de Saint BasileG. Defective human interleukin-2 receptor γ chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells. Proc Natl Acad Sci USA1994;91:9466–70.
18.
IshiiN, AsaoH, KimuraY. Impairment of ligand binding and growth signaling of mutant IL-2 receptor γ-chains in patients with X-linked severe combined immunodeficiency. J Immunol1994;1309–17.
19.
ClarkPA, LesterT, de AlwisM, JonesA, KinnonC. Unambiguous assignment of carrier status for females in X-linked severe combined immunodeficiency families based on direct mutational analy-sis. In: CaragolI, EspanolT, FontanG, MatamorosN, editors. Progress in immune deficiency V. Barcelona: Springer-Verlag Iberica, 1995:139–40.
20.
PuckJM, PepperAE, BedardP-M, LaframboiseR. Female germ line mosaicism as the origin of a unique IL-2 receptor γ-chain mutation causing X-linked severe combined immunodeficiency. J Clin Invest1995;95:895–9.
21.
PepperAE, BuckleyRH, SmallTN, PuckJM. Two mutational hotspots in the interleukin-2 receptor γ chain gene causing human X-linked severe combined immunodeficiency. Am J Hum Gen1995;57:564–71.
22.
QazilbashMH, WalshCE, RussellSM, NoguchiM, MannMM, LeonardWJ, LiuJM. A retroviral vector for gene therapy of X-linked SCID. J Hematother1995;4:91–8.
23.
CandottiF, JohnstonJA, PuckJM, SugamuraK, O'SheaJJ, BlaeseRM. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency. Blood1996;87:3097–102.
24.
TaylorN, UribeL, SmithS, JahnT, KohnDB, WeinbergK. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the γc gene. Blood1996;87:3103–7.
25.
Hacein-BeyS, Cavazzana-CalvoM, Le DeistF, Dautry-VarsatA, HivrozC, RiviereI, DanosO, HeardJM, SugamuraK, FischerA, de Saint BasileG. γc gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. Blood1996;87:3108–16.
26.
MiyajimaA, KitamuraT, HaradaN, YokotaT, AraiK. Cytokine receptors and signal transduction. Annu Rev Immunol1992;10:295–331.
27.
TagaT, KishimotoT. Signaling mechanisms through cytokine receptors that share signal transducing receptor components. Curr Opin Immunol1995;7:17–23.
28.
PennicaD, ShawKJ, SwansonTA, MooreMW, SheltonDL, ZioncheckKA, RosenthalA, TagaT, PaoniNF, WoodWI, GoeddelD. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem1995;270:10915–22.
29.
RussellSM, KeeganAD, HaradaN, NakamuraY, NoguchiM, LelandP, FriedmannMC, MiyajimaA, PuriRK, PaulWE, LeonardWJ. Interleukin-2 receptor γ chain: a functional component of the inter-leukin-4 receptor. Science1993;262:1880–3.
30.
NoguchiM, NakamuraY, RussellSM, ZieglerSF, TsangM, CaoX, LeonardWJ. Interleukin-2 receptor γ chain: a functional compo-nent of the interleukin-7 receptor. Science1993;262:1877–80.
31.
KondoM, TakeshitaT, IshiiN, NakamuraM, WatanabeS, AraiK, SugamuraK. Sharing of the interleukin-2 receptor γ chain between receptors for IL-2 and IL-4. Science1993;262:1874–7.
32.
KondoM, TakeshitaT, HiguchiM, NakamuraM, SudoT, NishikawaS-I, SugamuraK. Functional participation of the IL-2 recep-tor γ chain in IL-7 receptor complexes. Science1994;364:1453–4.
33.
RussellSM, JohnstonJA, NoguchiM, KawamuraM, BaconCM, FriedmannM, BergM, McVicarDW, WitthuhnBA, SilvennoinenO, GoldmanAS, SchmalstiegFC, IhleJN, O'SheaJJ, LeonardWJ. Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: Implications for XSCID and XCID. Science1994;266:1042–5.
34.
KimuraM, IshiiN, NakamuraM, Van SnickJ, SugamuraK. Sharing of the IL-2 receptor γ chain with the functional IL-9 receptor complex. Int Immunol1995;7:115–20.
35.
GiriJG, AhdiehM, EisenmanJ, ShanebeckK, GrabsteinK, KumatkiS, NamenA, ParkLS, CosmanD, AndersonD. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J1994;13:2822–30.
36.
LeonardWJ. The defective gene in X-linked severe combined immunodeficiency encodes a shared interleukin receptor subunit: implications for cytokine pleiotropy and redundancy. Curr Opin Immunol1994;6:631–5.
37.
SchindlerC, DarnellJEJr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem1995;64:621–51.
38.
JohnstonA, KawamuraM, KirkenRA, ChenYQ, BlakeTB, ShibuyaK, OrtaldoJR, McVicarDW, O'SheaJJ. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature1994;370:151–3.
39.
WitthuhnBA, SilvennoinenO, MiuraO, LaiKS, CwikC, LiuET, IhleJN. Involvement of the Jak-3 Janus kinase in signalling by inter-leukins 2 and 4 in lymphoid and myeloid cells. Nature1994;370:153–7.
40.
BoussiotisVA, BarberDL, NakaraiT, FreemanGJ, GribbenJG, BernsteinGM, d'AndreaAD, RitzJ, NadlerLM. Prevention of T cell anergy by signaling through the γc chain of the IL-2 receptor. Science1994;266:1039–42.
41.
MiyazakiT, KawaharaA, FujiiH, NakagawaY, MinamiY, LiuZ-J, OishiI, SilvennoinenO, WitthuhnBA, IhleJN, TaniguchiT. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science1994;266:1045–7.
42.
SchmalstiegFC, LeonardWJ, NoguchiM, BergM, RudloffHE, DenneyRM, DaveSK, BrooksEG, GoldmanAS. Missesnse mutation in exon 7 of the common γ chain gene causes a moderate form of X-linked combined immunodeficiency. J Clin Invest1995;95:1169–73.
43.
RussellSM, TayebiN, NakajimaH, RiedyMC, RobertJL, AmanMJ, MigoneT-S, NoguchiM, MarkertML, BuckleyRH, O'SheaJJ, LeonardWJ. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science1995;270:797–800.
44.
MacchiP, VillaA, GillaniS, SaccoMG, FrattiniA, PortaF, UgazioAG, JohnstonJA, CandottiF, O'SheaJJ, VezzoniP, NotarangeloLD. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature1995;377:65–8.
45.
KawaharaA, MinamiY, MiyazakiT, IhleJN, TaniguchiT. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc Natl Acad Sci USA1995;92:8724–8.
LinJ-X, MigoneT-S, TsangM, FriedmannM, WeatherbeeJA, ZhouL, YamauchiA, BloomET, MietzJ, JohnS, LeonardWJ. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, Il-7, IL-13, and IL-15. Immunity1995;2:331–9.
48.
GreenlundA, FarrarM, VivianoBL, SchreiberR. Ligand-induced IFN-γ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J1995;13:1591–600.
49.
FriedmannMC, MigoneT-S, RussellSM, LeonardWJ. Different interleukin 2 receptor β-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc Natl Acad Sci USA1996;93:2077–82.
50.
PeschonJ, MorrisseyPJ, GrabsteinKH, RamsdellFJ, MaraskovskyE, GliniakBC, ParkLS, ZieglerSF, WilliamsDE, WareCB, MeyerJD, DavisonBL. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med1994;180:1955–60.
51.
von Freeden-JeffryU, VieiraP, LucianLA, McNeilT, BurdachSE, MurrayR. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med1995;181:1519–26.
52.
MigoneT-S, LinJ-X, CeresetoA, MulloyJC, O'SheaJJ, FranchiniG, LeonardWJ. Constitutively activation Jak-STAT pathway in T cells transformed with HTLV-I. Science1995;269:79–81.
53.
DanialNN, PernisA, RothmanPB. Jak-STAT signaling induced by the v-abl oncogene. Science1995;260:1875–7.
54.
OhashiT, MasudaM, RuscettiSK. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood1995;84:1454–62.
55.
HarrisonDA, BinariR, NahreiniTS, GilmanM, PerrimonN. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neo-plasia and developmental defects. EMBO J1995;14:2857–65.
56.
MeydanN, GrunbergT, DadiH, ShaharM, ArpaiaE, LapidotZ, LeederJS, FreedmanM, CohenA, GazitA, LevitzkiA, RoifmanCM. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature1995;379:645–8.
57.
HenthornPS, SombergRL, FimianaVM, PuckJM, PattersonDF, FelsburgPJ. IL-2Rγ gene microdeletion demonstrates that canine X-linked severe combined immunodeficiency is a homologue of the human disease. Genomics1994;23:69–74.
58.
DiSantoJP, MullerW, Guy-GrandD, FischerA, RajewskyK. Lymphoid development in mice with a targeted deletion of the inter-leukin 2 receptor γ chain. Proc Natl Acad Sci USA1995;92:377–81.
59.
CaoX, ShoresEW, Hu-LiJ, AnverM, KelsallBL, RussellSM, DragoJ, NoguchiM, GrinbergA, BloomET, PaulWE, KatzSI, LovePE, LeonardWJ. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity1995;2:223–38.
60.
ThomisDC, GurniakCB, TivolE, SharpeAH, BergLJ. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science1995;270:794–7.
61.
NosakaT, van DeursenJMA, TrippRA, ThierfelderWE, WitthuhnBA, McMickleAP, DohertyPC, GrosveldGC, IhleJN. Defective lymphoid development in mice lacking Jak3. Science1995;270:800–2.
62.
ParkSY, SaijoK, TakahashT, OsawaM, AraseH, HirayamaN, MiyakeK, NakauchiH, ShirasawaT, SaitoT. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity1995;3:771–82.
63.
d'AndreaAD. Cytokine receptors in congenital hematopoietic disease. N Engl J Med1994;330:839–46.
64.
de la ChapelleA, TraskelinAL, JuvonenE. Truncated erythro-poietin receptor causes dominantly inherited benign human erythrocy-tosis. Proc Natl Acad Sci USA1993;90:4495–9.
65.
AmselemS, DuquesnoyP, AttreeO, NovelliG, BousninaS, Postel-VinayMC, GoossensM. Laron dwarfism and mutations of the growth hormone receptor gene. N Engl J Med1989;321:989–95.
66.
DongF, HoefslootLH, SchelenAM, BroedersCA, MeijerY, VeermanAJ, TouwIP, LowenbergB. Identification of a nonsense mutation in the granulocyte-colony-stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci USA1994;91:4480–4.
